GlassScriptPhysician profile
Gretchen V Gerace
NPI 1801024070
$2,966.22
in general payments reported to CMS, 2019-2025
32 companies · $576 in 2025
The $576 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $205 · 2021: $250 · 2022: $387 · 2023: $481 · 2024: $326 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $405.74 | 2019-2025 | Veozah |
| Abbvie INC. | $382.34 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Pfizer INC. | $275.63 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $172.07 | 2019-2024 | Gardasil 9, Gardasil |
| Hologic Sales and Service, LLC | $170.28 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $169.43 | 2019-2025 | |
| Sage Therapeutics, LLC | $162.98 | 2022-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $151.12 | 2021-2025 | |
| Exeltis, USA INC. | $148.61 | 2023-2025 | Slynd |
| Lupin INC. | $103.24 | 2019-2021 | |
| Exact Sciences Corporation | $90.80 | 2025 | The Cologuard Plus Collection Kit |
| Agile Therapeutics, INC. | $81.39 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $65.79 | 2023-2025 | Myfembree, Gemtesa |
| Gynesonics, INC. | $57.50 | 2022 | |
| Amag Pharmaceuticals, INC. | $53.94 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $45.89 | 2019 | |
| Therapeuticsmd, INC. | $45.70 | 2019-2021 | |
| Myovant Sciences INC. | $38.64 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $37.02 | 2019-2021 | |
| Aspira Women'S Health INC | $34.99 | 2022 | |
| Evofem Biosciences, INC. | $33.30 | 2020-2021 | |
| Ethicon US, LLC | $30.44 | 2022 | |
| Allergan, INC. | $26.11 | 2019 | |
| Organon LLC | $25.53 | 2021-2023 | Nexplanon |
| Millicent US INC | $24.36 | 2025 | Intrarosa, Femring |
| Optumhealth Care Solutions, LLC | $23.74 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Amgen INC. | $23.13 | 2019 | |
| Duchesnay USA Incorporated | $22.49 | 2019 | |
| Meditrina | $19.36 | 2021 | |
| Avion Pharmaceuticals | $15.26 | 2019 | |
| Dexcom, INC. | $14.88 | 2023 | Dexcom G6 Transmitter |
| Pacira Pharmaceuticals Incorporated | $14.52 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gretchen Gerace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.